Heart Valve Voice US is partnering with Antidote Technologies, Inc. to simplify access to clinical trials involving heart valve disease. Clinical trials are necessary to ensure the development of new technologies and treatments for heart valve disease. Unfortunately, this research is often slowed because of difficulty recruiting patients to participate. If you interested in participating and qualify for the trial, we encourage you to seek more information.
Heart Valve Voice US is committed to supporting research and innovation that benefits people with heart valve disease. This is the first of several research tools we have planned to improve the diagnosis, treatment and management of heart valve disease.